Sanofi and Regeneron, AstraZeneca, Roche’s Genentech and GSK have provided support for the Living Well with COPD educational ...

A recent national study revealed ongoing symptom burden and communication gaps in COPD care, and provided physicians with ...

Inhaler misuse leading to inadequate medication delivery impacts a person's ability to manage symptoms of chronic obstructive pulmonary disease (COPD), and additional education about proper ...

Approximately two thirds of hospitalized adults with chronic obstructive pulmonary disease (COPD) received suboptimal treatment with inhalers, mainly resulting from errors, based on data from 96 ...

COPD patients, who experience difficulty breathing and frequent coughing and wheezing, require complicated therapies, supplemental oxygen and frequent hospital visits.

Inhaler misuse was high in hospitalized patients with COPD, with 69.4% of all inhalers at admission found to be misused, according to results published in Chronic Obstructive Pulmonary Diseases ...

Improve COPD Awareness and Education: The Alliance works to increase public understanding of COPD, addressing stigma and empowering patients with knowledge.

Because of this, doctors usually start COPD patients with bronchodilators and other treatments like education and exercise programs before they prescribe inhaled steroids.

Among patients hospitalized with a diagnosis of COPD, two-thirds of inhalers assessed at admission are misused.